J. Brown, C. Farquhar, J. Beck, C. Boothroyd, and E. Hugues, Clomiphene and anti-oestrogens for ovulation induction in PCOS, Cochrane Database Syst Rev, vol.4, p.2249, 2009.

A. Badawy and A. Gibreal, Clomiphene citrate versus tamoxifen for ovulation induction in women with PCOS : a prospective randomized trial, Eur J Obstet Gynecol Reprod Biol, vol.159, pp.151-155, 2011.

H. Salazar, A. K. Godwin, M. B. Daly, P. B. Laub, M. Hogan et al., Microscopic benign and invasive malignant neoplasms and a cancer-prone phenotype in prophylactic oophorectomies, J Natl Cancer Inst, vol.88, pp.1810-1830, 1996.

B. A. Werness, A. M. Afify, K. L. Bielat, G. H. Eltabbakh, M. S. Piver et al., Altered surface and cyst epithelium of ovaries removed prophylactically from women with a family history of ovarian cancer, Hum Pathol, vol.30, pp.151-158, 1999.

J. F. Stratton, C. H. Buckey, D. Lowe, and B. Ponder, Comparison of prophylactic oophorectomy specimens from carriers and non carriers of a BRCA1 or BRCA2 gene mutation, J Natl Cancer Inst, vol.91, pp.626-634, 1999.

L. Resta, S. Russo, G. A. Colucci, and J. Prat, Morphologic precursors of ovarian epithelial tumors, Obstet Gynecol, vol.82, pp.181-187, 1993.

S. Plaxe, L. Deligdish, P. Dottino, and C. Cohen, Ovarian intraepithelial neoplasia demonstrated in patients with stage I ovarian carcinoma, Gynecol Oncol, vol.38, pp.67-72, 1990.

K. R. Mittal, A. Z. Jacquotte, J. L. Cooper, and R. Demopoulos, Controlateral ovary in unilateral ovarian carcinoma: a search for preneoplastic lesions, Int J Gynecol Patho, vol.12, pp.59-63, 1993.

F. Tressera, P. J. Grases, R. Labastida, and A. Ubeda, Histological features of the controlateral ovary in patients with unilateral ovarian cancer: a case control study, Gynecol Oncol, vol.71, pp.437-478, 1998.

G. Chene, K. Rahimi, M. Masson, A. M. Provencher, and D. , Surgical implications of the potential new tubal pathway for the ovarian carcinogenesis, J Minim Invasive Gynecol, vol.20, pp.153-162, 2013.

M. L. Carcangiu, P. Radice, S. Manoukian, G. Spatti, M. Gobbo et al.,

, European Journal of Histochemistry, vol.58, p.2251, 2014.

, Atypical epithelial proliferation in Fallopian tubes in prophylactic salpingooophorectomy specimens from BRCA 1 and BRCA 2 germline mutation carriers

, Int J Gynecol Pathol, vol.23, pp.35-40, 2003.

J. J. Nieto, J. Crow, M. Sundaresan, N. Constantinovici, C. W. Perret et al., Ovarian epithelial dysplasia in relation to ovulation induction and nulliparity, Gynecol Oncol, vol.82, pp.344-353, 2001.

G. Chene, F. Penault-llorca, L. Bouedec, G. Mishellany, F. Dauplat et al., Ovarian epithelial dysplasia after ovulation induction: time and dose effect, Human Reprod, vol.24, pp.132-140, 2009.

G. Chene, J. Dauplat, N. Radosevic-robin, A. Cayre, F. Penault-llorca et al., about serous ovarian carcinogenesis, Crit Rev Oncol Hematol, vol.88, pp.134-177, 2013.

G. Chene, J. Dauplat, I. Raoelfils, Y. J. Bignon, A. Cayre et al., Ovarian epithelial dysplasia: Description of a dysplasia scoring scheme, Ann Pathol, vol.31, pp.3-10, 2011.

G. Chene, I. Raoelfils, A. Cayre, J. Dauplat, Y. J. Bignon et al., Don't forget fallopian tubes! A morphologic and immunohistochemical study about Fallopian tubes with genetic risk

, Gynecol Obstet Fertil, vol.40, pp.14-22, 2012.

I. Yanai-inbar, S. Siriaunkgul, and S. G. Silverberg, Mucosal epithelial proliferation of the fallopian tube: a particular association with ovarian serous tumor of low malignant potential?, Int J Gynecol Pathol, vol.14, pp.107-120, 1995.

J. M. Piek, P. J. Van-diest, and R. P. Zweemer, Dysplastic changes in prophylactic removed fallopian tubes of women predisposed to developping ovarian cancer, J Pathol, vol.195, pp.451-457, 2001.

P. W. Schloosshauer, C. J. Cohen, F. Penault-lllorca, C. R. Miranda, Y. J. Bignon et al., Prophylactic oophorectomy, Cancer, vol.98, pp.2599-606, 2003.

B. Chang, G. Liu, F. Xue, D. G. Rosen, X. L. Wang et al., ALDH1 expression correlates with favorable prognosis in ovarian cancers, Modern Pathol, vol.22, pp.817-840, 2009.

L. Deligdish, J. Gil, H. Kerner, H. S. Wu, D. Beck et al., Ovarian dysplasia in prophylactic oophorectomy specimens: cytogenetic and morphometric correlations, Cancer, vol.86, pp.1544-50, 1999.

A. Mahdavi, T. Pejovic, and F. Nezhat, Induction of ovulation and ovarian cancer: a critical review of the literature, Fertil Steril, vol.85, pp.819-845, 2006.

A. Corakci, S. Filiz, E. Caliskan, C. Dalcik, S. Ozeren et al., The effects of ovulation induction on ovarian epithelium dysplasia scores and Ki67 expression: an experimental study on rats, Int J Gynecol cancer, vol.15, pp.866-71, 2005.

C. Celik, K. Gezginc, M. Aktan, A. Acar, S. T. Yaman et al., Effects of ovulation induction on ovarian morphology: an animal study, Int J Gynecol Cancer, vol.14, pp.600-606, 2004.

Z. Ozcan, H. Celik, B. Gurates, H. I. Ozercan, F. Nanay et al., Effects of ovulation induction agents on ovarian surface epithelium in rats, Reprod Biomed Online, vol.19, pp.314-332, 2009.

C. R. Lacoste, A. Clemenson, S. Lima, R. Lecointre, M. Peo'ch et al., Tuboovarian dysplasia in relatioship with ovulation in rats, Fertil Steril, vol.99, pp.1768-73, 2013.

M. Y. Williams-brown, S. M. Salih, X. Xu, T. D. Veenstra, M. Saeed et al., The effect of tamoxifen and raloxifen on estrogen metabolism and endometrial cancer risk, J Steroid Mol Biol, vol.126, pp.78-86, 2011.

F. Neri and T. Maggino, Surveillance of endometrial pathologies, especially for endometrial cancer, of breast cancer patients under tamoxifen treatment, Eur J Gynaecol Oncol, vol.30, pp.357-60, 2009.

D. Vicus, B. Rosen, J. Lubinski, S. Domchek, N. D. Kauff et al., Tamoxifen and the risk of ovarian cancer in BRCA1 mutation carriers, Gynecol Oncol, vol.115, pp.135-142, 2009.

A. J. Swerdlow and M. E. Jones, Ovarian cancer risk in premenopausal and perimenaopausal women treated with Tamoxifen: a case-control study, Br J Cancer, vol.96, pp.850-855, 2007.

I. Cohen, Y. Beyth, R. Tepper, J. Shapira, Y. Zalel et al., Ovarian tumors in postmenopausal breast cancer patients treated with tamoxifen, Gynecol Oncol, vol.60, pp.54-62, 1996.

O. Lavie, T. Longacre, Y. Segev, and A. Husain, Ovarian carcinosarcomas associated with prolonged use of tamoxifen: case reports, Int J Gynecol Cancer, vol.19, pp.1521-1524, 2009.

H. Pickel, O. Reich, and K. Tamussino, Bilateral atypical hyperplasia of the fallopian tube associated with tamoxifen : a report of two cases, Int J Gynecol Pathol, vol.17, pp.284-289, 1999.

B. A. Diwan, L. M. Anderson, and J. M. Ward, Proliferative lesions of oviduct and uterus in CD-1 mice exposed prenatally to tamoxifen, Carcinogenesis, vol.18, pp.2009-2023, 1997.

A. Y. Ting, B. F. Kimler, C. J. Fabian, and B. K. Petroff, Tamoxifen prevents premalignant changes of breast, but not ovarian cancer in rats at high risk for both diseases, Cancer Prev Res, vol.1, pp.546-53, 2008.

S. Lima, A. Clemenson, B. Trombert, R. Lecointre, C. R. Lacoste et al., Morphological and immunohistochemical analysis in ovaries and tubes of tamoxifen, letrozole and clomifene-treated rats, Arch Gynecol Obstet, 2014.

A. K. Folkins, E. A. Jarboe, A. Saleemuddin, Y. Lee, M. J. Callahan et al., A candidate precursor to pelvic serous cancer (p53 signature) and their prevalence in ovaries and fallopian tubes from women with BRCA mutations, Gynecol oncol, vol.109, pp.168-73, 2008.

C. P. Crum, R. Drapkin, D. Kindelberger, F. Medeiros, F. Miron et al., Lessons from BRCA: the tubal fimbria emerges as an origin for pelvic serous cancer, Clin Med Res, vol.5, pp.35-44, 2007.

C. B. Powell, E. Kenley, L. M. Chen, B. Crawford, J. Mclennan et al., Riskreducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy, J Clin Oncol, vol.23, pp.127-159, 2005.

A. Finch, P. Shaw, B. Rosen, J. Murphy, S. A. Narod et al., Clinical and pathologic findings of prophylactic salpingooophorectomies in 159 BRCA1 and BRCA2 carriers, Gynecol Oncol, vol.100, pp.58-64, 2006.

N. N. Nik, R. Vang, I. M. Shih, and R. J. Kurman, Origin and pathogenesis of pelvic (ovarian, tubal, and primary peritoneal) serous carcinoma, Annu Rev Pathol, vol.9, pp.27-45, 2014.

G. Emons, G. Fleckenstein, B. Hinney, A. Huschmand, and W. Heyl, Hormonal interactions in endometrial cancer, Endoc Relat Cancer, vol.7, pp.227-269, 2000.

M. P. Ponnusamy and S. K. Batra, Ovarian cancer: emerging concept on cancer stem cells, J Ov Research, vol.4, pp.1-9, 2008.

S. Liu, C. Ginestier, C. , E. Foco, H. Kleer et al., BRCA1 regulates human mammary stem/progenitor cell fate, Proc Natl Acad Sci, vol.105, pp.1680-85, 2008.
URL : https://hal.archives-ouvertes.fr/hal-01431959

C. Ginestier, J. Wicinski, N. Cervera, F. Monville, P. Finetti et al., Retinoid signaling regulates breast cancer stem cell differentiation, Cell Cycle, vol.8, pp.3297-302, 2009.
URL : https://hal.archives-ouvertes.fr/hal-01431955

M. R. Heerma-van-voss, P. Van-der-groep, and B. Joost, Van der Wall E, Van diset PJ. Expression of the stem cell marker ALDH1 in the normal breast of BRCA1 mutation carriers, Breast Cancer Res Treat, vol.123, pp.611-613, 2010.

C. Ginestier, M. H. Hur, C. , E. Monville, F. Dutcher et al., ALDH1 is a marker of normal and malignant human mammary sterm cells and a predictor of poor clinical outcome, Cell Sterm Cell, vol.1, pp.555-67, 2007.

K. Penumatsa, S. L. Edassery, A. Barua, M. J. Bradaric, and J. L. Luborsky, Differential expression of aldehyde dehydrogenase 1a1 (ALDH1) in normal ovary and serous ovarian tumors, J Ov Research, vol.28, pp.1-13, 2010.

C. Ginestier, C. Iovino, and F. , European Journal of Histochemistry, vol.58, p.2251, 2014.

C. Tarpin, M. Diebel, and B. Esterni,

, Aldehyde dehydrogenase 1 positive cancer stem cells mediate metastasis and poor clinical outcome in inflammatory breast cancer, Clin Cancer Res, vol.16, pp.45-55, 2010.

S. Deng, X. Yang, H. Lassus, S. Liang, S. Kaur et al., Distinct expression levels and atterns of sterm cell marker, Aldehyde Dehydrogenase Isoform 1 (ALDH1), in human epithelial cancers, Plos One, vol.5, p.10277, 2010.

I. Kryczek, S. Liu, M. Roh, L. Vatan, W. Szeliga et al., Expression of aldehyde dehydrogenase and CD133 defines ovarian cancer stem cells, Int J Cancer, vol.130, pp.29-39, 2012.

N. Auersperg, The stem-cell profile of ovarian surface epithelium is reproduced in the oviductal fimbriae, with increased stem-cell marker density in distal parts of the fimbriae, Int J Gynecol Pathol, vol.32, pp.444-53, 2013.

D. Y. Paik, D. M. Janzen, A. M. Schafenacker, V. S. Velasco, M. S. Shung et al., Stem-like epithelial cells are concentrated in the distal end of the fallopian tube: a site for injury and serous cancer initiation, Stem cells, vol.30, pp.2487-97, 2012.

G. Chene, F. Penault-llorca, L. Bouedec, G. Mishellany, F. Dauplat et al., Ovarian epithelial dysplasia and prophylactic oophorectomy for genetic risk, Int J Gynecol Cancer, vol.19, pp.65-72, 2009.